Thyroid hormone, thyroid hormone receptors, and cancer: a clinical perspective
The DOI matches its Crossref record; 79 of the 79 references it cites were found in a registry or an index.
Abstract
Thyroid hormones (THs) may play a role in diseases other than hyper- and hypothyroidism. Several lines of evidence suggest tumor-promoting effects of TH and TH receptors. They are possibly mediated by phosphatidylinositol-3-kinase and MAPK and involve among others stimulation of angiogenesis via αvβ3. Thus, an increased risk for colon, lung, prostate, and breast cancer with lower TSH has been demonstrated in epidemiological studies, even suggesting a TH dose effect on cancer occurrence. Furthermore, higher TH levels were associated with an advanced clinical stage of breast and prostate cancer. In rodent models, TH stimulated growth and metastasis of tumor transplants, whereas hypothyroidism had opposite effects. In clinical studies of glioblastoma and head and neck cancer, hypothyroid patients showed longer survival than euthyroid patients. Also, patients with renal cell cancer that were treated with the tyrosine kinase inhibitor sunitinib and developed hypothyroidism in due course showed significantly longer survival than patients that remained euthyroid. Development of hypothyroidism was an independent predictor for survival in two studies. Yet, it is still possible that hypothyroidism is only a surrogate marker for treatment efficacy and does not positively influence treatment outcome by itself. Future cancer treatment studies, especially with substances that can induce hypothyroidism, should therefore be designed in a way that allows for an analysis of thyroid function status and its contribution on treatment outcome.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Thyroid dysfunction, mostly hypothyroidism, is an adverse effect of checkpoint inhibitor treatment for cancer, and has been associated with longer survival in these studies (36,37).”
From Evidence-Based Use of Levothyroxine/Liothyronine Combinations in Treating Hypothyroidism: A Consensus Document (2021) · cites this paper as [37]
In the citing paper
“Thyroid dysfunction, mostly hypothyroidism, is an adverse effect of checkpoint inhibitor treatment for cancer, and has been associated with longer survival in these studies [36, 37].”
From Evidence-Based Use of Levothyroxine/Liothyronine Combinations in Treating Hypothyroidism: A Consensus Document (2021) · cites this paper as [37]
Citations
Cites
Physiological and Molecular Basis of Thyroid Hormone Action
Yen, P. M. (2001) · Physiological Reviews · doi:10.1152/physrev.2001.81.3.1097 · Cited by 2,011 · cited 1×
“Two different genes, THRA on chromosome 17 and THRB on chromosome 3, encode TRa and TRb respectively (Yen 2001).”
BackgroundDefining the role of hypoxia-inducible factor 1 in cancer biology and therapeutics
Semenza, G. L. (2010) · Oncogene · doi:10.1038/onc.2009.441 · Cited by 1,712
Interaction of oestrogen receptor with the regulatory subunit of phosphatidylinositol-3-OH kinase
Simoncini, T., Hafezi-Moghadam, A., Brazil, D. P., Ley, K., Chin, W. W., & Liao, J. K. (2000) · Nature · doi:10.1038/35035131 · Cited by 1,436 · cited 1×
“…that TH and TRb could also act through a different mechanism: the ligand-bound TRb could activate the phosphatidylinositol-3-kinase (PI3K) pathway via phosphorylation of Akt/PKB within minutes, which subsequently affected gene expression (Simoncini et al. 2000, Lei et al. 2004, Cao et al. 2005).”
BackgroundMolecular Aspects of Thyroid Hormone Actions
Cheng, S.-Y., Leonard, J. L., & Davis, P. J. (2010) · Endocrine Reviews · doi:10.1210/er.2009-0007 · Cited by 1,384 · cited 1×
“In addition, truncated TR isoforms exist that lack amino terminal domains and DNA binding (Cheng et al. 2010).”
BackgroundPTEN and the PI3-Kinase Pathway in Cancer
Chalhoub, N., & Baker, S. J. (2009) · Annual Review of Pathology: Mechanisms of Disease · doi:10.1146/annurev.pathol.4.110807.092311 · Cited by 1,245 · cited 1×
“And the oncogenic PI3K pathway, activated by TH via TRa/b and the S1 site of avb3, facilitates cell growth and survival and inhibits apoptosis (Chalhoub & Baker 2009).”
BackgroundBergh, J. J., Lin, H.-Y., Lansing, L., Mohamed, S. N., Davis, F. B., Mousa, S., & Davis, P. J. (2005) · Endocrinology · doi:10.1210/en.2005-0102 · Cited by 497
Rapid nongenomic actions of thyroid hormone
Hiroi, Y., Kim, H.-H., Ying, H., Furuya, F., Huang, Z., Simoncini, T., Noma, K., Ueki, K., Nguyen, N.-H., Scanlan, T. S., et al. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0601600103 · Cited by 380 · cited 1×
“Cao et al. (2009) could demonstrate PI3K activation in TRa overexpressing neuronal cells and Hiroi et al. (2006) found TRa1 association with p85a followed by phosphorylation of Akt/PKB, a downstream target of PI3K, and activation of endothelial nitric oxide synthase. avb3 as TR Bergh et al. (2005)…”
BackgroundA Mutation in the Thyroid Hormone Receptor Alpha Gene
Bochukova, E., Schoenmakers, N., Agostini, M., Schoenmakers, E., Rajanayagam, O., Keogh, J. M., Henning, E., Reinemund, J., Gevers, E., Sarri, M., et al. (2012) · New England Journal of Medicine · doi:10.1056/nejmoa1110296 · Cited by 379 · cited 1×
“The clinical differences between patients with resistance to TH (RTH) due to TRb and TRa mutations further demonstrate that distinct physiological roles for the TR isoforms exist (Refetoff & Dumitrescu 2007, Bochukova et al. 2012, Ferrara et al. 2012, van Mullem et al. 2012).”
BackgroundFactors Related to Inflammation of the Ovarian Epithelium and Risk of Ovarian Cancer
Ness, R. B., Grisso, J. A., Cottreau, C., Klapper, J., Vergona, R., Wheeler, J. E., Morgan, M., & Schlesselman, J. J. (2000) · Epidemiology · doi:10.1097/00001648-200003000-00006 · Cited by 363 · cited 2×
“history of ovarian cancer) (Ness et al. 2000).”
BackgroundInfluentialA Mutation in the Thyroid Hormone Receptor Alpha Gene
Bochukova, E. G., Schoenmakers, N. A., Agostini, M., Schoenmakers, E., Rajanayagam, O., Keogh, J. M., Henning, E., Reinemund, J., Gevers, E. F., Sarri, M., et al. (2012) · UCL Discovery (University College London) · Cited by 327
Research works printed but not linked: 1
- Speranza G Rubinstein L Ivy SP Harris PJ 2011 Correlation between adverse event reports of hypothyroidism and clinical response in patients treated with vascular endothelial growth factor receptor inhibitors (VEGFR-I). Journal of Clinical Oncology29(Supplement: ASCO Meeting Abstracts Part 1) abstract 2602 · doi:10.1200/jco.2011.29.15_suppl.2602
Cited by
Items 101–180 of 180
Quan, T., Cockburn, J., Dhesy‐Thind, S., Bane, A. L., Leong, H. S., Geleff, C., Devion, C., Ajel, N., & Jerzak, K. J. (2024) · Current Oncology · doi:10.3390/curroncol31050176 · Cited by 10
“While targeted therapies are available for most patients with BC, particularly those with ER and/or PR positive disease and those with HER2+ BC, resistance to treatment is common and novel therapeutic targets and biomarkers are of interest.”
BackgroundHyperthyroïdie et cancer du sein : y a-t-il une association ?
Cordel, E., Reix, N., Molière, S., & Mathelin, C. (2018) · Gynécologie Obstétrique Fertilité & Sénologie · doi:10.1016/j.gofs.2018.01.010 · Cited by 7
Thyroid dysfunctions and autoimmunity in breast cancer patients: a prospective case-control study
Jha, C. K., Mishra, A., Yadav, S., Agarwal, G., Singh, S., Chand, G., Agarwal, A., & Mishra, S. K. (2020) · Archives of Endocrinology and Metabolism · doi:10.20945/2359-3997000000284 · Cited by 8
“Both chemotherapy and radiotherapy have the propensity to induce hypothyroidism (13,19,28-30).”
InfluentialThyroid hormone: a resurgent treatment for an emergent concern
Breitzig, M., Alleyn, M. D., Lockey, R. F., & Kolliputi, N. (2018) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.00336.2018 · Cited by 12
Lei, Z., Zeng, B., Wu, L., Deng, Q., & Guo, D. (2022) · Endokrynologia Polska · doi:10.5603/ep.a2022.0020 · Cited by 6
Tobi, D., Krashin, E., Davis, P. J., Cody, V., Ellis, M. H., & Ashur‐Fabian, O. (2022) · Frontiers in Endocrinology · doi:10.3389/fendo.2022.895240 · Cited by 9
“Thyroid hormones (THs) are essential for the normal development of tissues, as well as for the regulation of cellular metabolism, cell structure and membrane transport (1).”
BackgroundKim, M., Lee, J. W., Hyun, M. K., & Song, Y. S. (2024) · Endocrinology and Metabolism · doi:10.3803/enm.2023.1815 · Cited by 6
“Many preclinical studies have been conducted in recent decades to determine how thyroid hormones exert their tumor growth-promoting effect [2].”
BackgroundMieritz, M. G., Sørensen, K., Aksglæde, L., Mouritsen, A., Hagen, C. P., Hilsted, L., Andersson, A., & Juul, A. (2014) · European Journal of Endocrinology · doi:10.1530/eje-13-0847 · Cited by 6
Use of anti-thyroid drugs in patients with hyperthyroidism: a case for shared decision-making
Giovanella, L., & Verburg, F. A. (2019) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-019-04476-4 · Cited by 6
Elomaa, K., Spick, M. P., Gan, E. H., Pearce, S. H. S., & Geifman, N. (2025) · European Thyroid Journal · doi:10.1530/etj-24-0393 · Cited by 5
“There is some evidence suggesting patients with hyperthyroidism have increased risks of cancer (31, 32), so logically treatment might reduce these risks, but the interactions between hyperthyroidism and cancer will be complex and vary by primary site.”
Sirakov, M., Claret, L., & Plateroti, M. (2021) · Frontiers in Endocrinology · doi:10.3389/fendo.2021.725708 · Cited by 8
Prevalencia de cáncer en pacientes con hipotiroidismo: análisis mediante herramientas de big data
Díez, J. J., Cabrera, L., Iglesias, P., Benavent, M., Argüello, G., López, G., Parralejo, A., & Leal, J. (2022) · Endocrinología Diabetes y Nutrición · doi:10.1016/j.endinu.2022.05.004 · Cited by 5
Wang, B., Luo, Y., Liu, T., Xu, S., Pei, J., Liu, J., & Yu, J. (2024) · Frontiers in Endocrinology · doi:10.3389/fendo.2024.1308208 · Cited by 5
“Hypothyroidism may contribute to carcinogenesis, as thyroid hormones and TSH possess the capacity to directly stimulate tumorigenesis through various mechanisms encompassing cell surface receptors, estrogen pathways, augmented angiogenesis, and gene expression modi fi cation (19).”
BackgroundThyroid disorders and mammographic density in Spanish women: Var-DDM study
Pedraza-Flechas, A. M., Lope, V., Vidal, C., Sánchez‐Contador, C., Santamariña, C., Pedraz‐Pingarrón, C., Moreo, P., Ascunce, N., Miranda-García, J., Llobet, R., et al. (2017) · The Breast · doi:10.1016/j.breast.2017.04.011 · Cited by 5
Asghar, M. Y., Knuutinen, T., Holm, E., Nordström, T., Nguyen, V. D., Zhou, Y., & Törnquist, K. (2022) · Cancers · doi:10.3390/cancers14235838 · Cited by 6
αvβ3 Integrin Expression and Mitogenic Effects by Thyroid Hormones in Chronic Lymphocytic Leukemia
Abadi, U., Weisz, A., Kidron, D., Katzav, A., Hercbergs, A. H., Davis, P. J., Ellis, M. H., & Ashur‐Fabian, O. (2021) · Journal of Clinical Medicine · doi:10.3390/jcm10081766 · Cited by 5
Sagliocchi, S., Acampora, L., & Cicatiello, A. G. (2023) · Journal of Basic and Clinical Physiology and Pharmacology · doi:10.1515/jbcpp-2023-0155 · Cited by 4
Rehman, G., Srivastav, A. K., Rizvi, S., Chhabra, A., & Tyagi, R. K. (2025) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2025.112585 · Cited by 5
Majos, A., Hogendorf, P., Skulimowski, A., Spychalski, M. I., Strzelczyk, J., & Durczyński, A. (2020) · Cancer Biomarkers · doi:10.3233/cbm-201595 · Cited by 5
“Moeller and Fuhrer review [3] cites studies which proved statistical connection between occurrence and course of cancer and hyperthyroidism (ovarian, prostate, breast cancer or general cancer incidence) [4–7], as well as longer survival among the patients who developed hypothyroidism as side effect…”
Radioactive Iodine Treatment in Hyperthyroidism and Cancer Mortality—A Still Controversial Issue
Biondi, B. (2021) · JAMA Network Open · doi:10.1001/jamanetworkopen.2021.26361 · Cited by 4
Gao, T., Luo, S., Li, H., Su, Z., & Wen, Q. (2024) · Heliyon · doi:10.1016/j.heliyon.2024.e27080 · Cited by 3
“While T4 replacement medication is frequently used after thyroid gland surgery, hyperthyroidism caused by excessive T4 production may require suppression therapy to control cancer progression [45 – 47].”
BackgroundPrevalence of cancer in patients with hypothyroidism: Analysis using big data tools
Díez, J. J., Cabrera, L., Iglesias, P., Benavent, M., Argüello, G., López, G., Parralejo, A., & Leal, J. (2023) · Endocrinología Diabetes y Nutrición (English ed ) · doi:10.1016/j.endien.2023.08.004 · Cited by 6
Zheng, Y., Zhang, L., Xiang, Q., Li, J., Yao, Y., Wu, Y., Sun, H., & Zhao, H. (2025) · Journal of Environmental Sciences · doi:10.1016/j.jes.2025.01.006 · Cited by 3
Mazza, A. D. (2025) · Hormone and Metabolic Research · doi:10.1055/a-2698-0521 · Cited by 5
“Though direct evidence is limited, has been shown to influence NAD biosynthesis enzymes and mitochondrial + interaction has been implicated in obesity, insulin resistance, and aging, suggesting that thyroid–sirtuin signaling may represent”
Stromal cells in normal colon and colon cancers: importance of thyroid hormone signaling
Reslinger, M., & Plateroti, M. (2025) · Cell Death and Disease · doi:10.1038/s41419-025-08005-0 · Cited by 8
Jensen, A., Gottschau, M., Christensen, J., Lindquist, S., Aalborg, G. L., Rosthøj, S., Grand, M. K., Pedersen, J., Nøhr, B., & Kjær, S. K. (2026) · Cancer Epidemiology Biomarkers & Prevention · doi:10.1158/1055-9965.epi-25-1668 · Cited by 3
Puhr, H. C., Reiter, T. J., El-Mahrouk, M., Saliternig, L., Wolf, P. S., Mair, M. J., Steindl, A., Paireder, M., Asari, R., SCHOPPMANN, S. F., et al. (2021) · Cancers · doi:10.3390/cancers13205050 · Cited by 3
“Furthermore, the loss of normal functions of thyroid receptors might also play an important role as a contributor to cancer development as well as metastasis [6].”
BackgroundWhat is thyroid function in your just-diagnosed cancer patient?
Hercbergs, A. H., Mousa, S. A., Lin, H., & Davis, P. J. (2023) · Frontiers in Endocrinology · doi:10.3389/fendo.2023.1109528 · Cited by 3
Zhao, X., Wang, Y., Zhou, L., Ye, A., & Zhu, Q. (2025) · Scientific Reports · doi:10.1038/s41598-025-85807-4 · Cited by 4
Haque, M. M., Voitsitskyi, T., & Lee, J. (2022) · Scientific Reports · doi:10.1038/s41598-022-08799-5 · Cited by 3
Methyl and propylparaben elicit distinct thyroid-disrupting effects in a rat thyroid cell model
Greco, A., Coperchini, F., Franchi, E., Denegri, M., Croce, L., Teliti, M., Calì, B., Dorji, T., Magri, F., & Rotondi, M. (2025) · Emerging contaminants · doi:10.1016/j.emcon.2025.100592 · Cited by 2
Higher Free T 4 Levels Are Associated with an Increased Risk of Any Solid Cancer
Hershman, J. M. (2016) · Clinical Thyroidology · doi:10.1089/ct.2016;28.332-333 · Cited by 2
Triiodothyronine lowers the potential of colorectal cancer stem cells in vitro
Rostkowska, O. M., Olejniczak-Kęder, A., Spychalski, P., Szaryńska, M., & Kobiela, J. (2022) · Oncology Reports · doi:10.3892/or.2022.8458 · Cited by 2
“Concurrently, hypothyroidism was found to exert opposite effects and may induce apoptosis of cancer cells (5,6).”
BackgroundMäkimattila, S., Harjutsalo, V., Feodoroff, M., & Groop, P. (2024) · Journal of the Endocrine Society · doi:10.1210/jendso/bvae054 · Cited by 2
“Thyroid dysfunction may be involved in carcinogenesis as thyroid hormones and TSH can directly enhance tumor proliferation and angiogenesis through their cell surface receptors, and they may also affect gene expression regulation [ 4].”
BackgroundWu, L. M., Xu, S., Yang, B. W., Yang, J. J., Yee, C., & Cirillo, N. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms232214096 · Cited by 2
Thyroid hormone, PD-L1, and cancer
Lin, H., Chen, Y., Li, Z., Shih, Y.-J., Davis, P. J., Whang-Peng, J., & Wang, K. (2019) · Journal of Cancer Research and Practice · doi:10.4103/jcrp.jcrp_26_19 · Cited by 2
“[6] An increased risk for colon, lung, prostate, and breast cancers with lower thyroid-stimulating hormone defined as a state of subclinical hyperthyroidism has been confirmed in epidemiological studies.[45] These studies suggest that thyroid hormone level affects the occurrence of cancer.”
BackgroundEnvironmental Paraben Exposure and Risk of Thyroid Cancer and Benign Nodules: A Pilot StudyPreprint
Wu, N.-X., Zhu, S., Liu, C., Yan, Y.-H., Wang, J., Hong, A.-B., Wang, L.-Q., Zeng, Q., Sun, J., Chen, D., et al. (2021) · Research Square · doi:10.21203/rs.3.rs-1009533/v1 · Cited by 2
The ecdysone receptor promotes or suppresses proliferation according to ligand levelPreprint
Perez‐Mockus, G., Cocconi, L., Alexandre, C., Aerne, B. L., Salbreux, G., & Vincent, J. (2023) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2023.02.10.527985 · Cited by 2
Qureshi, K., Rathore, M., Waheed, N. U. A., Yasmin, N., Lodhi, S., Gondal, A. J., & Nakhshab (2022) · Pakistan Journal of Medical and Health Sciences · doi:10.53350/pjmhs20221611177 · Cited by 1
Impact of Thyroid Cancers on Thyroid Hormones among Patients Attended Tripoli University Hospital
Elbaruni, S. A., Almehdawi, M., Badi, L., Ferrara, N., & Bilkhier, N. (2024) · AlQalam Journal of Medical and Applied Sciences · doi:10.54361/ajmas.2471017 · Cited by 1
Dong, L., Zhang, N., Chen, J., Dong, P., Mao, N., Li, H., & Wang, A. (2024) · Molecular Carcinogenesis · doi:10.1002/mc.23788 · Cited by 1
“5,6 Specifically, a complex relationship exists between thyroid and liver in health and disease.”
Jensen, A., Gottschau, M., Christensen, J., Lindquist, S., Aalborg, G. L., Rosthøj, S., Grand, M. K., Pedersen, J., Kjær, S. K., & Nøhr, B. (2025) · International Journal of Cancer · doi:10.1002/ijc.70007 · Cited by 2
“10,11,46,47 38 For example, Weng et al. 18 conducted a large prospective cohort study using data from the Women's Health Initiative, including 134,122 women, and found a similar 9% decreased risk of breast cancer among women with hypo-thyroidism.”
Zhang, S., Niu, S., Zhou, L., Liu, Y., & Deng, M. (2025) · International Journal of Endocrinology · doi:10.1155/ije/7915829 · Cited by 1
“For instance, studies have found that thyroid hormones can regulate multiple signaling pathways related to tumor progression, such as PI3K/AKT and MAPK pathways [27].”
Impact of isolated TSH levels in and out of normal range on different tissues
Wahl, R. (2016) · European Journal of Endocrinology · doi:10.15496/publikation-16920 · Cited by 1
Treatment-induced hypothyroidism in head-and-neck cancer – Is it a crystal ball?
Puri, T. (2018) · Cancer Research Statistics and Treatment · doi:10.4103/crst.crst_15_19 · Cited by 1
Bednarczuk, T. (2021) · Springer eBooks · doi:10.1007/978-3-030-63277-9_9 · Cited by 2
Ibrahim, T. S., Taher, E. S., Altyar, A. E., & Rizg, W. Y. (2021) · International Journal of Pharmacology · doi:10.3923/ijp.2021.300.307 · Cited by 1
Chen, Y., Dong, H., Qu, B., Ma, X., & Lu, L. (2024) · Frontiers in Endocrinology · doi:10.3389/fendo.2024.1379607 · Cited by 1
“Research in animal models and human studies indicated that thyroid hormone regulated cellular processes associated with age-related diseases such as diabetes, cardiovascular complications, neurocognitive dysfunction, and cancer (47, 48).”
Pulickal, S. G., Sebastian, N., Bhaskaran, R., & Aparna, P. (2021) · Journal of Radiotherapy in Practice · doi:10.1017/s1460396920001144 · Cited by 1
Clinical challenges in the management of endocrine side effects of immuno-oncological therapies
Wolf, P. S., & Scherer, T. (2021) · memo - Magazine of European Medical Oncology · doi:10.1007/s12254-021-00773-7 · Cited by 1
“hormone action with cancer proliferation by promoting growth, differentiation and metabolism [12], while pre-existing hypothyroidism in patients with cancer”
BackgroundThe relationship between thyroid and cancer (focus on breast cancer)
Costa, M. F., & Greiger, M. C. (2023) · Open Journal of Clinical and Medical Case Reports · doi:10.52768/2379-1039/2155
Zaboli, E., Hamedani, S. M. M. G., Movahedirad, S. M., Naghshvar, F., Ebrahimi, P., Ebrahimi, S., Babaeian, M., Rezaei, S., Hedayatizadeh‐Omran, A., & Alizadeh‐Navaei, R. (2024) · Preprints.org · doi:10.20944/preprints202401.1087.v1 · Cited by 1
Janssen, L. G. M., Pijl, H., Charehbili, A., Kranenbarg, E. M., Kessels, L. W., Ziekenhuis, D., van Bochove, A., & van Laarhoven, H. W. M. (2015)
Actual, E., Antonia, D., & Despaigne, N. (2015)
Cockburn, J., Pond, G. R., Dhesy‐Thind, S., Bane, A. L., & Narod, S. A. (2015)
Classical and Non-Classical Thyroid Hormone Intracellular Pathways Involved in T Lymphoma Growth
Arcos, M. L. B., Sterle, H., Cayrol, F., Flaqué, M. C. D., Valli, E., Paulazo, M. A., Klecha, A. J., & Cremaschi, G. (2015) · Immunology Endocrine & Metabolic Agents - Medicinal Chemistry · doi:10.2174/187152221501150710125255
“Hyperthyroidism has been described as a risk factor for the development of ovarian [52], pancreas [53], lung and prostate [54] cancers.”
BackgroundInfluence of Insulin Resistance and TSH on the Risk of Malignancy of Thyroid Nodule
Erdal, S., Pekkolay, Z., & Kemal, T. A. (2018) · International Archives of Endocrinology Clinical Research · doi:10.23937/2572-407x.1510014
“Studies suggest that there may be a positive relationship between TSH elevation and thyroid cancer [9,10].”
BackgroundAyan, D., Eren, N., Kara, Z. M. Y., KIZILKAYA, H. O., Aksan, D. U., & Serin, E. (2018) · Turkiye Klinikleri Journal of Medical Sciences · doi:10.5336/medsci.2018-61794
Study on the Relationship between Non-Small Cell Lung Cancer and Thyroid Hormone
赵, 晓. (2020) · Advances in Clinical Medicine · doi:10.12677/acm.2020.103031
The Role of Thyroid Hormone Receptor α1 in Cardiac Repair
Mourouzis, I. S. (2020) · Springer eBooks · doi:10.1007/978-3-030-36871-5_13
The influence of primary thyroid cancer to the prognosis of breast cancer: A SEER-based studyPreprint
Chen, X., Li, J., Wu, Q., Liu, H., Yuan, J., & Sun, S. (2021) · Research Square · doi:10.21203/rs.3.rs-290018/v1 · Cited by 1
Abbas, N., Yusuf, M., Akhtar, N., & Khan, R. A. (2021) · Nanotechnology Reviews · doi:10.1515/ntrev-2022-0020
“The ανβ3 integrin, containing binding sites, S1 and S2 [55], binds to the thyroid components, T3 and T4, with a lower affinity for T4 than T3.”
BackgroundCancer Risk and Its Dose-Response Association with Radioactive Iodine Treatment for Hyperthyroidism
Balcerek, M. I., & McLeod, D. S. A. (2022) · Clinical Thyroidology · doi:10.1089/ct.2022;34.13-16
“It is a difficult issue to study epidemiologically, with long follow-up times required and multiple potential confounding factors, not least of all that thyroid hormone excess itself may be associated with an increased risk of solid organ malignancy (10).”
Mitrović, B., Gluvic, Z. M., Obradovic, M. M., Lačković, M., Samardzic, V. S., Ćirić, J., & Isenović, E. R. (2016) · Medicinska istrazivanja · doi:10.5937/medist1602001m
“GHQm [Med (min–max)] 7 (1-38) 16 (8-32) 8 (3-13) Tabela 1.”
BackgroundInfluentialThe Association between Papillary Thyroid Carcinoma and Thyroid Stimulating Hormone (TSH)
Mamun, D. M. M. H., Sarker, D. K., Sabbir, D. M. I. G., Alam, D. M. F., & Rahman, D. M. A. (2023) · Scholars Journal of Applied Medical Sciences · doi:10.36347/sjams.2023.v11i03.020
Wang, M., Li, Z., Wang, Z., Ying, Y., Hua, M., Wang, H., Zeng, S., Zhang, Z., & Xu, C. (2023) · Research Square · doi:10.21203/rs.3.rs-3189263/v1 · Cited by 1
Thyroid Hormones Imbalances and Risk of Colorectal Cancer: a Meta-analysis
Asbaghi, O., Shimi, G., Davoodi, S. H., Pourvali, K., Eslamian, G., & Zand, H. (2023) · Journal of Gastrointestinal Cancer · doi:10.1007/s12029-023-00979-4
“T3 also acts on S1 site of αvβ3 receptors and activates phosphatidylinositol 3-kinase (PI3K) signaling which provokes hypoxia-inducible factor-1α (HIF1α) and stimulates angiogenesis [39].”
Case Report of Hyperprogression of Lung Cancer Mediated by Hyperthyroidism
陈, 耿. (2024) · Advances in Clinical Medicine · doi:10.12677/acm.2024.1451668
Marotta, N., Furini, C., Trimarchi, F., Santi, D., & Spaggiari, G. (2025) · L Endocrinologo · doi:10.1007/s40619-025-01612-1
“…modulare diverse pathways implicate nella tumorigenesi (come, ad esempio, il fosfatidil inositolo-3-chinasi, l’angiogenesi e l’immunoreattività) [3], mentre al contempo pazienti ipertiroidei sembrano esposti a un rischio aumentato per lo sviluppo di varie neoplasie, sebbene i risultati non…”
Wang, W., Liu, N., Wang, S., Yu, C., Pan, L., & Zhang, M. (2025) · Clinical Proteomics · doi:10.1186/s12014-025-09554-4
“Further analysis identified modifications in thyroid hormone signaling [43], cyclic guanosine monophosphate (cGMP)-protein kinase G (PKG) signaling [44], and aldosterone synthesis and secretion pathways [45], which are involved in various physiological processes, including metabolism, vascular…”
Gao, B., Zhang, C., Wang, D., Luo, D., Shan, Z., Teng, W., Tao, T., & Li, J. (2025) · International Journal of Women s Health · doi:10.2147/ijwh.s552719
“51 Additionally, when PI3K is activated by T3 or T4, it triggers the expression of the α-subunit of hypoxia-inducible factor 1 (HIF-1), a transcription factor.”
Falstie‐Jensen, A. M., Esen, B. Ö., Kjærsgaard, A., Lorenzen, E. L., Jensen, J. D., Reinertsen, K. V., Dekkers, O. M., Ewertz, M., & Cronin-Fenton, D. P. (2020) · Figshare · doi:10.6084/m9.figshare.13088302
Wang, X., Liu, X., Li, Y., Tang, M., Meng, X., Chai, Y., Zhang, L., & Zhang, H. (2023) · Figshare · doi:10.6084/m9.figshare.24123827
Thyroid Hormone T3 Induces DNA Damage Response in Breast Cancer Cells
Movshovitz, S., Sinberger, L. A., Trabelsi, K., Bar-on, A., Sonnenblick, A., Salmon‐Divon, M., & Listovsky, T. (2026) · International Journal of Molecular Sciences · doi:10.3390/ijms27020668
“The thyroid hormone (TH) receptors (THRs) are known to play a role in regulating cellular processes such as aging, cancer, and degenerative diseases, suggesting they possess tumor suppressor activity [1–3].”
Bidoli, C., Reslinger, M., Sieffert, C., Weis, B., LAVERNY, G., Gerdol, M., & Plateroti, M. (2026) · Scientific Reports · doi:10.1038/s41598-026-40397-7
Association Between Thyroid Dysfunction and Breast Cancer Risk Among Adult Women
Tran, T. V. T. (2021) · theses.fr (ABES) · doi:10.70675/5a3920c0zded5z489cz9d96zc204e8bf08d3 · Cited by 1
Li, Z. J., Song, T., Zhang, Y., Wang, Y., & Sun, H. (2026) · Frontiers in Oncology · doi:10.3389/fonc.2026.1821253
Şeflek, H. N., Erbayram, F. Z., Ertuş, E. B., MUTLU, E. G., Alpa, Ş., & TÜRKOĞLU, F. N. (2026) · Naunyn-Schmiedeberg s Archives of Pharmacology · doi:10.1007/s00210-026-05661-7
“In addition, our results align with previous reports suggesting that PTU can exert antitumor effects by suppressing proliferative and anti-apoptotic signaling in cancer cells (Moeller and Führer 2013; Sabatier et al. 2012).”
Cano, R. Y., Gómez, S. E., Ferrando, M., Redondo, A. L., Zyla, L. E., Bruna, F., Creydt, V. P., Fontana, C. M. L., & Carón, R. W. (2026) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2026.112915
Rehders, M., Kerp, H., Nica, R., Ecker, R., Führer, D., & Brix, K. (2026) · International Journal of Molecular Sciences · doi:10.3390/ijms27209345
“Furthermore, the precise mechanistic links between thyroid dysfunction and various cancers, including thyroid cancer, have yet to be fully elucidated [42,43].”
Self-citation
Metadata
- Authors
- Moeller, L. C., & Führer, D.
- Affiliations
- University of Duisburg-Essen (DE)
- ORCID
- Moeller, Lars C
- Venue
- Endocrine-Related Cancer
- Publisher
- Bioscientifica
- Published
- 2013-04-01
- Volume
- 20
- Issue
- 2
- Pages
- R19-R29
- ISSN
- 1351-0088 (ISSN-L)
- 1479-6821
- OpenAlex
- W2128280017
- Cited by
- 184
- References
- 76
- Citations by year
- 2026: 7 · 2025: 14 · 2024: 16 · 2023: 14 · 2022: 18 · 2021: 18 · 2020: 15 · 2019: 19 · 2018: 13 · 2017: 10 · 2016: 14 · 2015: 18 · 2014: 8
- FWCI
- 1.95
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Endocrine Related Cancer (publishedVersion)
- PubMed (publishedVersion)
- Universitätsbibliographie, Universität Duisburg-Essen (submittedVersion)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Thyroid Disorders and Treatments
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Thyroid Cancer Diagnosis and Treatment
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Growth Hormone and Insulin-like Growth Factors
- Keywords
- thyroid hormones, thyroid hormone receptor, cancer, hypothyroidism, tumor promotion, phosphatidylinositol 3-kinase, MAPK signaling, angiogenesis, alpha v beta 3 integrin, thyroid-stimulating hormone, colon cancer, lung cancer, prostate cancer, breast cancer, glioblastoma, head and neck cancer, renal cell carcinoma, sunitinib, tyrosine kinase inhibitors, cancer survival, metastasis
- MeSH terms
- Animals, Disease Models, Animal, Humans, Neoplasms, Receptors, Thyroid Hormone, Thyroid Hormones
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.